SUBSCRIBE TO OUR NEWSLETTER

Resources

FEATURED BLOG POST

Time to Rethink RECIST 1.1?

The standard criteria for managing the use of medical imaging in clinical oncology trials—RECIST (Response Evaluation...

Read More  
25 February 2021

Time to Rethink RECIST 1.1?
5 February 2021

Radiopharmaceuticals Hotter Than Ever - Infographic
26 January 2021

Monica E. Luchi, MD, Joins The Bracken Group Consultancy

19 January 2021

Remembering 2020, Predicting 2021
16 December 2020

New Digital Health Center of Excellence Reminds Us That the "Food and Drug Administration" Is Becoming Something Very Different
10 November 2020

The Clinical Path for Innovation Meeting: Overview and Origins
28 September 2020

Dr. Colin G. Miller Named to the Board of the International Society on Osteoarthritis and Imaging
23 September 2020

FDA Guidance States Once Again that ClinicalTrials.gov Reporting will be Enforced
7 August 2020

The Public Weighs in on Improving ClinicalTrials.gov
3 August 2020

Providing Critical Guidance and Connections for a Private Equity Firm Considering a Large Investment
CONTACT US

Ask us anything.

We would be delighted to hear from you and discuss our consulting services. Please call +1 215 648 1208 to chat with us directly. Or write to us using the form provided here. We look forward to collaborating with you.
It's almost like getting free consulting...

Subscribe to our monthly hand-crafted newsletter for the latest insights on clinical trial trends and the life science industry.

Subscribe Now  

12 Penns Trail, Newtown, PA 18940
+1 215 648 1208

© 2020 the bracken group - Privacy Policy

12 Penns Trail, Newtown, PA 18940
+1 215 648 1208

© 2020 the bracken group - Privacy Policy